Approvals of drugs with uncertain benefit–risk profiles in Europe

Published: 2 September 2015
Author(s): Rita Banzi, Chiara Gerardi, Vittorio Bertele', Silvio Garattini
Issue: September 2015
Section: Original Article
Read on EJIM website

This paper examines conditional approvals that allow the marketing of medicines with unsettled benefit–risk profiles in the European Union.

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness